MRVI compared with GPN: revenue, margins and what each company keeps, and the suppliers and customers both name

MRVIMaravai Lifesciences Holdings, Inc.

Mkt capRevenueRevenue

GPNGlobal Payments Inc

Mkt capRevenueRevenue

Compare

MRVIMaravai Lifesciences Holdings, Inc.

GPNGlobal Payments Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MRVI

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±27.5%▼−0.32%×0.01

May 8 '26±29.0%▲+23.10%×0.80

Q1 FY26±26.3%▲+9.20%×0.35

Q3 FY25±25.4%▼−0.69%×0.03

GPN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.3%▼−0.87%×0.09

Q1 FY26±8.8%▲+0.23%×0.02

= impliedMRVI realized, solidGPN realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

Feb 18 '26

±7.2%

▲+16.47%

×2.29

Q3 FY25±13.2%▲+3.71%×0.28

MRVIMaravai Lifesciences Holdings, Inc.

7.80▼−7.79%· post 7.80

Mkt cap$2.0BRevenue$51MQ2 FY26Revenue$186MFY25

GPNGlobal Payments Inc

96.91▲+13.05%· post 96.29

ClosedOct 30 '26

Mkt cap$25.6BRevenue$3.3BQ2 FY26Revenue$7.1BFY25

Compare

ClosedOct 30 '26

MRVIMaravai Lifesciences Holdings, Inc.

GPNGlobal Payments Inc

7.80▼−7.79%post 7.80

Price

96.91▲+13.05%post 96.29

$2.0B

Mkt cap

$25.6B

Q2 FY26$51M

Revenue

$3.3BQ2 FY26

FY25$186M

Revenue

$7.1BFY25

MRVI7.80▼−7.79%vsGPN96.91▲+13.05%ClosedOct 30 '26